CAROLYN BLAIR: Open Payments
NPI 1255614129 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 23 payments from 14 companies in 2025. Trend: 2023 $15 · 2024 $0 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $83 |
| Janssen Biotech, Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $57 |
| GENZYME CORPORATION | 1 | $39 |
| Galderma Laboratories, L.P. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $26 |
Products named: Bimzelx, DUPIXENT, TREMFYA, RINVOQ, Winlevi, CIBINQO, Cabtreo, SPEVIGO.
Industry payments across MD — which companies pay providers there.
